Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (671-680 of 934) with videos related to

Pageof 94
Sort By:
JACC. Cardiovascular Imaging|February 13, 2009
Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomographyQuynh A Truong, Jagmeet P Singh, Christopher P Cannon, et al.
Hypertension (Dallas, Tex. : 1979)|August 3, 2016
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor AlogliptinWilliam B White, Craig A Wilson, George L Bakris, et al.
Journal of the American College of Cardiology|February 2, 2008
Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarctionC Michael Gibson, Yuri B Pride, Jacqueline L Buros, et al.
Journal of Thrombosis and Thrombolysis|May 1, 2002
"Hot" unstable angina--is it worse than subacute unstable angina? Results from the GUARANTEE RegistryN K Sekaran, D J Moliterno, J J Ferguson, et al.
Journal of the American Heart Association|October 11, 2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) TrialPontus Andell, Stefan K James, Christopher P Cannon, et al.
Journal of the American College of Cardiology|February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO studyPatricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Clinical Cardiology|October 30, 2013
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH RegistryFátima Rodriguez, Christopher P Cannon, Ph Gabriel Steg, et al.
Clinical Therapeutics|April 14, 2025
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current EvidenceMario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, et al.
The American Journal of Cardiology|April 14, 2009
Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) AllianceBrahmajee K Nallamothu, Harlan M Krumholz, Eric D Peterson, et al.
The American Journal of Cardiology|January 12, 2020
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)Jurrien M Ten Berg, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Pageof 94

Showing results (671-680 of 934) with videos related to

Sort By:
Pageof 94
JACC. Cardiovascular Imaging|February 13, 2009
Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomographyQuynh A Truong, Jagmeet P Singh, Christopher P Cannon, et al.
Hypertension (Dallas, Tex. : 1979)|August 3, 2016
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor AlogliptinWilliam B White, Craig A Wilson, George L Bakris, et al.
Journal of the American College of Cardiology|February 2, 2008
Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarctionC Michael Gibson, Yuri B Pride, Jacqueline L Buros, et al.
Journal of Thrombosis and Thrombolysis|May 1, 2002
"Hot" unstable angina--is it worse than subacute unstable angina? Results from the GUARANTEE RegistryN K Sekaran, D J Moliterno, J J Ferguson, et al.
Journal of the American Heart Association|October 11, 2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) TrialPontus Andell, Stefan K James, Christopher P Cannon, et al.
Journal of the American College of Cardiology|February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO studyPatricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Clinical Cardiology|October 30, 2013
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH RegistryFátima Rodriguez, Christopher P Cannon, Ph Gabriel Steg, et al.
Clinical Therapeutics|April 14, 2025
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current EvidenceMario Enrico Canonico, Marisa Avvedimento, Raffaele Piccolo, et al.
The American Journal of Cardiology|April 14, 2009
Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) AllianceBrahmajee K Nallamothu, Harlan M Krumholz, Eric D Peterson, et al.
The American Journal of Cardiology|January 12, 2020
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)Jurrien M Ten Berg, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Pageof 94